Press Releases

MicrobioSeq Boosts Microbial Community Research with Long-Read Metagenomic Sequencing

CD Genomics RNA-Solutions Platform Announces the Launch of Nanopore Direct RNA Sequencing

Lonza Strengthens Micronization Portfolio with the Introduction of X-Ray Powder Diffraction Capability in Monteggio (CH)

CLINICAL TRIALS SPECIALISTS COREX LOGISTICS APPOINTS NANA PEKHMASHVILI TO HEAD GEORGIA OFFICE

Clinical trials logistics specialists COREX Logistics has announced the appointment of Nana Pekhmashvili as Country Head of its Georgian office located in Tbilisi.

Curebase Names Medical Research Veteran Sean Lynch as VP of Clinical Operations

Curebase, a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.

With 3Brain AG's Accura-3D microchip, a first-in-class cell-electronic interface enters the market

3Brain AG and Swiss research and technology organization CSEM unveil a first-in-class 3D CMOS microchip to probe intelligent networks within the complex cytoarchitecture of electroactive 3D tissues and brain organoids

Clinical Standards for Chemistry Laboratory Use

Inizio strengthens leadership team with two key appointments

BioAgilytix announces appointment of Dr. Linda Robbie as Chief Operating Officer

BioAgilytix Labs, LLC (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in all phases of drug development, has announced the appointment of Dr. Linda Robbie as Chief Operating Officer. This appointment was effective as of August 9th, 2022.

Jumo Health Celebrates Ranking on the 2022 Inc. 5000 List of Fastest Growing Companies

Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it is among the fastest growing private companies as reported by Inc. Magazine in its prestigious Inc. 5000 list.

Anju Introduces eTMF Master for Electronic Trial Master File Management in Clinical Studies

Saama Appoints Andrew J. (A.J.) Mills as Company’s Chief Commercial Officer

Saama announces appointment of life science industry sales and marketing expert A.J. Mills as company's Chief Commercial Officer.

Saama Collaborates with Merck to Build Machine Learning-Powered Clinical Data Layer to Strengthen Merck’s Clinical Development Capabilities

Saama announces multi-year agreement with Merck to leverage Saama's Life Science Analytics Cloud (LSAC) to build new clinical data layer to strengthen Merck’s clinical development capabilities and expedite pipeline progress.

GLOBAL CLINICAL TRIALS CONNECT 2022

“COLLABORATION, INNOVATION AND ENHANCING QUALITY IN CLINICAL TRIALS” Virtual Conference and Expo

U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

Alliance Pharma today announced they will be opening a bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.

Research from Beacon Biosignals Presented at Alzheimer's Association International Conference

The researchers concluded that automated analysis of EEG data is a promising way to stratify patients and track disease progression, while enabling better patient selection for clinical trials.

ChargePoint Technology bolsters growth strategy with key appointment

150 Orphan Drug Indication Approvals Trusted to Calyx IRT

Trial sponsors rely on Calyx IRT to ensure patient supply during rare disease treatment development

Signant Partners with Loftware for Adaptive Investigational Product Labeling

Signant Health, the leader in evidence generation for modern clinical trials, announced a partnership with Loftware to offer customers integrated clinical trial supply labeling and packaging capabilities. Loftware is the leading provider of labeling and regulated content solutions and can now be integrated with Signant’s SmartSignals™ Supplies solutions to provide customers with a seamless product label design, approval, and production process.

BioIVT Acquires Cypex, a Leading Manufacturer of Drug-metabolizing Enzymes

Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.